S21-064 Synthesis of EBC-46 (tigilanol tiglate) and Analogs for Treatment of Cancer and Other PKC-related Diseases Stanford scientists in Dr. Paul Wender's lab have developed a novel method to synthesize tigilanol tiglate (EBC-46) and related compounds from readily available starting materials. Paul Wender Nguyen Hong Quang Luu Zach Gentry Edward Njoo David Fanelli Owen Dennis McAteer
S15-370 Cell-Penetrating, Guanidinium-Rich Oligomers for Drug and Probe Delivery Stanford researchers have synthesized a highly effective molecule to transport drug conjugates across cell membranes. Colin McKinlay Paul Wender Robert Waymouth
S08-441 Oligocarbonate molecular transporters across biological barriers Stanford University researchers have developed a new family of oligocarbonate molecular transporters (OMTs) that penetrate cell membranes and tissues. Paul Wender Robert Waymouth James Hedrick Fredrik Nederberg Christina Cooley Brian Trantow Matthew Kiesewetter